NexGel (NXGL) Stock: Buy, Sell, or Hold?
NXGL - NexGel, Inc Common Stock
$0.17
0.00 (-2.52%)
▼
5d:
+0.0%
30d:
-49.91%
90d:
-67.79%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 10, 2026
Get Alerted When NXGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NXGL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NXGL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NXGL is currently trading at $0.17, which is considered oversold relative to its 30-day fair value range of $0.23 to $0.35. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.8) compared to its historical average (4.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NXGL is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.28.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+1049.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NXGL is in a strong downtrend. Immediate support is located at $0.16, while resistance sits at $0.28.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+1049.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.23 -
$0.35
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1049.4% below Wall St target ($2.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.23 -
$0.35
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.16
Resistance Level
$0.28
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.79
Wall Street Target
$2.00
(+1049.4%)
Revenue Growth (YoY)
27.8%
Profit Margin
-51.3%
PE vs Historical
-0.8 vs 4.8
CHEAP
Share & Embed Analysis
Last updated: October 03, 2026 4:52 AM ET
Data refreshes hourly during market hours. Next update: 5:52 AM
Data refreshes hourly during market hours. Next update: 5:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 53 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 35 SELL |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 67 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 61 BUY |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$206 | 65 BUY |
